Optimization of anti-cancer drugs and a targeting molecule on multifunctional gold nanoparticles

Nahla Rizk, Nicolas Christoforou, Sungmun Lee

Research output: Contribution to journalArticlepeer-review

32 Scopus citations

Abstract

Breast cancer is the most common and deadly cancer among women worldwide. Currently, nanotechnology-based drug delivery systems are useful for cancer treatment; however, strategic planning is critical in order to enhance the anti-cancer properties and reduce the side effects of cancer therapy. Here, we designed multifunctional gold nanoparticles (AuNPs) conjugated with two anti-cancer drugs, TGF-β1 antibody and methotrexate, and a cancer-targeting molecule, folic acid. First, optimum size and shape of AuNPs was selected by the highest uptake of AuNPs by MDA-MB-231, a metastatic human breast cancer cell line. It was 100 nm spherical AuNPs (S-AuNPs) that were used for further studies. A fixed amount (900 μl) of S-AuNP (3.8 ×108 particles/ml) was conjugated with folic acid-BSA or methotrexate-BSA. Methotrexate on S-AuNP induced cellular toxicity and the optimum amount of methotrexate-BSA (2.83 mM) was 500 μl. Uptake of S-AuNPs was enhanced by folate conjugation that binds to folate receptors overexpressed by MDA-MB-231 and the optimum uptake was at 500 μl of folic acid-BSA (2.83 mM). TGF-β1 antibody on S-AuNP reduced extracellular TGF-β1 of cancer cells by 30%. Due to their efficacy and tunable properties, we anticipate numerous clinical applications of multifunctional gold nanospheres in treating breast cancer.

Original languageBritish English
Article number185704
JournalNanotechnology
Volume27
Issue number18
DOIs
StatePublished - 23 Mar 2016

Keywords

  • breast cancer
  • folic acids
  • gold nanoparticles
  • methotrexate
  • TGF-β

Fingerprint

Dive into the research topics of 'Optimization of anti-cancer drugs and a targeting molecule on multifunctional gold nanoparticles'. Together they form a unique fingerprint.

Cite this